TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Idexx Laboratories Norge AS
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
15,739
|
14,077
|
11,687 |
| Financial expenses |
12
|
8
|
0 |
| Earnings before taxes |
3,852
|
2,791
|
2,209 |
| Total assets |
39,985
|
31,259
|
24,891 |
| Current assets |
38,939
|
30,899
|
24,440 |
| Current liabilities |
21,549
|
15,755
|
11,492 |
| Equity capital |
17,817
|
14,823
|
12,661 |
| - share capital |
120
|
120
|
120 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
44.6%
|
47.4%
|
50.9% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
24.5%
|
19.8%
|
18.9% |
| Return on assets (ROA) |
9.7%
|
9.0%
|
8.9% |
| Current ratio |
180.7%
|
196.1%
|
212.7% |
| Return on equity (ROE) |
21.6%
|
18.8%
|
17.4% |
| Change turnover |
1,662
|
2,390
|
-90,861 |
| Change turnover % |
12%
|
20%
|
-89% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.